6-Bromo-2-naphthol

CAS No. 15231-91-1

6-Bromo-2-naphthol( —— )

Catalog No. M28682 CAS No. 15231-91-1

6-Bromo-2-naphthol is an electrophilic carbene intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    6-Bromo-2-naphthol
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Bromo-2-naphthol is an electrophilic carbene intermediate.
  • Description
    6-Bromo-2-naphthol is an electrophilic carbene intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ceramidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    15231-91-1
  • Formula Weight
    223.069
  • Molecular Formula
    C10H7BrO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Oc1ccc2cc(Br)ccc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Draper JM, et al. Discovery and evaluation of inhibitors of human ceramidase. Mol Cancer Ther. 2011 Nov;10(11):2052-61.
molnova catalog
related products
  • pTH-Related Protein ...

    pTH-Related Protein (1-40) (human, mouse, rat) stimulates calcium uptake in rat intestinal cells through PTHR1 receptor and PKCα/β signaling pathways. pTH-Related Protein (1-40) up-regulates parathyroid hormone 1 receptor (PTHR1) protein, four transcellular calcium transporters, potential vanillin member 6 (TRPV6), calcium-binding protein-D9K (CaBP-D9k), sodium-calcium Exchanger 1 (NCX1) and plasma membrane calcium ATPase 1 (PMCA1).

  • Ethyl -2-ethoxy-1-[[...

    Ethyl -2-ethoxy-1-[[(2-(1Htetrazol-5-yl)biphenyl-4-yl-) methyl]

  • D-Fructose-16-diphos...

    Fosfructose trisodium is a cytoprotective natural sugar phosphate for the potential treatment of sickle cell anemia cardiovascular ischemia and asthma. It acts by stimulating anaerobic glycolysis which generates adenosine triphosphate under ischemic conditions.